Literature DB >> 25083576

Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study.

Sujatha Thathapudi1, Vijayalakshmi Kodati, Jayashankar Erukkambattu, Anuradha Katragadda, Uma Addepally, Qurratulain Hasan.   

Abstract

BACKGROUND: Tumor necrosis factor-alpha (TNF-α) appears to be linked with hyperandrogenism (HA), increased insulin resistance (IR), and obesity (Ob), which were common features noted with polycystic ovarian syndrome (PCOS). Our aim was to study the role of TNF-α in the pathogenesis of IR and Ob in PCOS, as well as a C850T (rs1799724) polymorphism in the promoter region of the TNF-α gene, in a group of 204 PCOS patients and 204 age-matched healthy controls.
RESULTS: Significant differences were observed between PCOS patients and controls. All the PCOS had elevated body mass index, waist circumference, waist-to-hip ratio, fasting insulin, homeostatic model assessment (HOMA) score, and serum TNF-α when compared with controls (p<0.05). Genotype distribution for the C-850T polymorphism was observed with the frequency of the variant T allele being 0% in the PCOS group and 9% in the control group (p=0.0032).
CONCLUSIONS: In conclusion, our present results suggest that the TNF-α system might contribute to the pathogenesis of HA, Ob, and IR in PCOS independent of a polymorphism of the TNF-α C850T (rs1799724) in our population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25083576      PMCID: PMC4150372          DOI: 10.1089/gtmb.2014.0151

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  20 in total

1.  Appropriate BMI levels for PCOS patients in Southern China.

Authors:  Xiaoli Chen; Renmin Ni; Yaqin Mo; Lin Li; Dongzi Yang
Journal:  Hum Reprod       Date:  2010-02-18       Impact factor: 6.918

Review 2.  The role of TNFalpha and TNF receptors in obesity and insulin resistance.

Authors:  G S Hotamisligil
Journal:  J Intern Med       Date:  1999-06       Impact factor: 8.989

3.  No association between the -308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries.

Authors:  C R Milner; J E Craig; N D Hussey; R J Norman
Journal:  Mol Hum Reprod       Date:  1999-01       Impact factor: 4.025

Review 4.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

5.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Authors:  M Urbanek; R S Legro; D A Driscoll; R Azziz; D A Ehrmann; R J Norman; J F Strauss; R S Spielman; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 6.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

7.  Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.

Authors:  Soo Jin Chae; Jin Ju Kim; Young Min Choi; Kyu Ri Hwang; Byung Chul Jee; Seung Yup Ku; Chang Suk Suh; Seok Hyun Kim; Jung Gu Kim; Shin Yong Moon
Journal:  Hum Reprod       Date:  2008-06-24       Impact factor: 6.918

8.  Androgen excess in women: experience with over 1000 consecutive patients.

Authors:  R Azziz; L A Sanchez; E S Knochenhauer; C Moran; J Lazenby; K C Stephens; K Taylor; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

Review 9.  The genetics of polycystic ovary syndrome.

Authors:  R S Legro
Journal:  Am J Med       Date:  1995-01-16       Impact factor: 4.965

10.  Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor-alpha and polycystic ovary syndrome.

Authors:  S Korhonen; E-L Romppanen; M Hiltunen; A Mannermaa; K Punnonen; M Hippeläinen; S Heinonen
Journal:  Gynecol Endocrinol       Date:  2002-08       Impact factor: 2.260

View more
  8 in total

1.  Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women.

Authors:  Eun Youn Roh; Jong Hyun Yoon; Eun Young Song; Jin Ju Kim; Kyu Ri Hwang; Soo Hyun Seo; Sue Shin
Journal:  J Assist Reprod Genet       Date:  2016-10-29       Impact factor: 3.412

2.  Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update.

Authors:  Subeka Abraham Gnanadass; Yogamaya Divakar Prabhu; Abilash Valsala Gopalakrishnan
Journal:  Arch Gynecol Obstet       Date:  2021-01-13       Impact factor: 2.344

3.  Developmental Programming: Gestational Exposure to Excess Testosterone Alters Expression of Ovarian Matrix Metalloproteases and Their Target Proteins.

Authors:  Muraly Puttabyatappa; Ashleigh Irwin; Jacob D Martin; Makeda Mesquitta; Almudena Veiga-Lopez; Vasantha Padmanabhan
Journal:  Reprod Sci       Date:  2017-03-16       Impact factor: 3.060

4.  Chronic inflammation in polycystic ovary syndrome: A case-control study using multiple markers.

Authors:  Soumik Goswami; Subhadip Choudhuri; Basudev Bhattacharya; Rana Bhattacharjee; Ajitesh Roy; Satinath Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Int J Reprod Biomed       Date:  2021-04-22

5.  High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis.

Authors:  Lingling Gao; Yang Gu; Xianghua Yin
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

6.  Effects of IL-18 on the proliferation and steroidogenesis of bovine theca cells: Possible roles in the pathogenesis of polycystic ovary syndrome.

Authors:  Hong Yuan Zhang; Fu Fan Zhu; Ying Jun Zhu; Yuan Jing Hu; Xu Chen
Journal:  J Cell Mol Med       Date:  2020-12-07       Impact factor: 5.295

Review 7.  Markers of insulin resistance in Polycystic ovary syndrome women: An update.

Authors:  Chantal Anifa Amisi
Journal:  World J Diabetes       Date:  2022-03-15

8.  The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome.

Authors:  Özden Özdemir Başer; Ayşe Yeşim Göçmen; Demet Aydoğan Kırmızı
Journal:  Turk J Obstet Gynecol       Date:  2022-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.